The antibiotic teixobactin—developed a decade ago by Northeastern University professors Kim Lewis and Slava Epstein in ...

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, ...

[10] Therefore, treatment of anthrax with amoxicillin should not ... Since the goal of this project is to provide initial prophylaxis of antibiotics until additional resources become available ...

The discovery sheds light on how certain bacteria -- including strains that cause food poisoning and anthrax -- form spores for survival.

Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has ...

In the US, there are only about 80 to 140 brucellosis cases reported each year, and they're mostly caused by B. melitensis and B. abortus. People tend to get infected by eating raw (unpasteurized) ...

“The key contributing factors to AMR in the region include the overuse and misuse of antibiotics, poor infection control in healthcare settings, and limited access to innovative diagnostics and ...

Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has launched a suite of antibiotic products for injection, including ...